Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 166
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05072522 | A Study of SKLB1028 in Patients With Advanced Solid Tumor | ||
| NCT05475717 | A Study to Explore the Efficacy of Alprostadil Liposomes Injection in the Prevention of CI-AKI | ||
| NCT02859948 | A Study of SKLB1028 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia | ||
| NCT05513664 | Real-World Effectiveness of Osimertinib for Patients With Non-Small Cell Lung Cancer | ||
| NCT04921878 | A Study of Mitoxantrone Hydrochloride Liposome Injection in Chinese Patients With Advanced Solid Tumors | ||
| NCT04707079 | A Safety and Efficacy Study of Duvelisib in Relapsed/Refractory Follicular Lymphoma | ||
| NCT05705635 | A Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer | ||
| NCT04364997 | Study of Desvenlafaxine in Treating Major Depressive Disorder. | ||
| NCT04124484 | DBPR108 Tablets in Type 2 Diabetes Mellitus Patients | ||
| NCT05761028 | A Study of CM310 in Subjects With Moderate to Severe Asthma | ||
| NCT07116824 | HB1801 Combined Treatment of HER2-positive Breast Cancer | ||
| NCT05100303 | A Study to Evaluate the Tolerance and Efficacy of Mitoxantrone Hydrochloride Liposome Injection Combined With Cytarabine in Patients With Acute Myeloid Leukemia (AML) | ||
| NCT07412353 | A Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of SYH2085 | ||
| NCT04931823 | Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors | ||
| NCT03456388 | Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Healthy Subjects | ||
| NCT05009966 | Study of SYSA1801 in the Treatment of Claudin( CLDN) 18.2 Positive Advanced Malignant Solid Tumor | ||
| NCT04309968 | Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Anti-tumor Activity of SYHA1801 Monotherapy in Patients With Advanced Solid Tumors | ||
| NCT04060290 | Real-world Study for the Safety of Albumin-Bound Paclitaxel in Malignant Tumors | ||
| NCT04460820 | A Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection | ||
| NCT03669562 | The Safety and Tolerability of Alprostadil Liposome for Injection in Healthy Adult Volunteers | ||
| NCT04716114 | A Study of SKLB1028 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory (R/R) AML With FLT3-Mutated | ||
| NCT01342042 | The Safety,Preliminary Pharmacodynamics and Pharmacokinetics Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus | ||
| NCT04015024 | A Clinical Study of SKLB1028 Capsule in the Treatment of Recurrence/Refractory AML Patients | ||
| NCT03199261 | A Study of Pharmacokinetic Comparison of Two Recombinant Exendin-4 Formulations in Chinese Healthy Male Subjects | ||
| NCT04161430 | A Study to Evaluate the Efficacy and Safety of DBPR108 100 mg in Type 2 Diabetes Mellitus Patients | ||
| NCT05345938 | A Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Acute Myeloid Leukemia | ||
| NCT06505395 | A Trial to Assess Efficacy, Safety, Pharmacokinetics of Octreotide Subcutaneous Injection in Patients With Gastroentero-pancreatic Neuroendocrine Tumor (GEP-NET) | ||
| NCT05150626 | A Study to Evaluate the Effect of Different Meal Types on the Pharmacokinetics of DBPR108 in Healthy Subjects | ||
| NCT03239119 | The Effectivity and Safety Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus | ||
| NCT05108545 | A Study of Amphotericin B Liposome for Injection in Patients With Persistent Neutropenia and Fever | ||
| NCT06492941 | A Study of Docetaxel for Injection (Albumin Bound) in Patients With Advanced Pancreatic Cancer | ||
| NCT05116111 | A Study To Evaluate the Safety, Tolerance, Pharmacokinetics/Pharmacodynamics and Efficacy of SYHA1402 Tablets For the Treatment of Patients With Diabetic Peripheral Neuropathy in China | ||
| NCT02597153 | Phase II Clinical Study of PLM60 for the Treatment of Cutaneous T Cell Lymphomas | ||
| NCT04886700 | Study of the SG001 Injection for Patients With Relapsed or Metastatic Uterine Cervical Cancer | ||
| NCT04718402 | A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Gastric Carcinoma | ||
| NCT06632574 | A Clinical Study of Paclitaxel Cationic Liposomes for the Treatment of Patients With Advanced Solid Tumors | ||
| NCT02059785 | Phase ⅡStudy of Pinocembrin Injection to Treat Ischemic Stroke | ||
| NCT04352413 | A Study of PLM60 in Subjects With Relapsed Small-cell Lung Cancer After Platinum-based First-Line Chemotherapy | ||
| NCT05369858 | A Mass Balance and Biotransformation Study of [14C]SKLB1028 in Chinese Healthy Male Subjects | ||
| NCT02856685 | A Study of Mitoxantrone Hydrochloride Liposome Infusion | ||
| NCT04983550 | Efficacy and Safety of SG001 Combined With PLD in Patients With Platinum-resistant Relapsed EOC | ||
| NCT04509466 | Clinical Study of Liposomal Mitoxantrone Hydrochloride Injection Combined With Pegaspargase in the Treatment of NKTCL | ||
| NCT04197323 | Alprostadil Liposomes for Injection for Lower Extremity Arteriosclerosis Obliteran | ||
| NCT02043756 | Phase I and Pharmacokinetic Study of Mitoxantrone Hydrochloride Liposome Injection | ||
| NCT06511739 | A Study to Evaluate the Efficacy and Safety of SYHX1901 Tablet in Non-segmental Vitiligo Patients | ||
| NCT04645901 | A Study of SYHA1805 in Healthy Adult Subjects | ||
| NCT05715840 | Efficacy and Safety Study of First-line Treatment With SG001 Plus Chemotherapy ± Bevacizumab Versus Placebo Plus Chemotherapy ±Bevacizumab for Recurrent, or Metastatic Cervical Cancer With PD-L1 Positive (CPS≥1) | ||
| NCT05068141 | A Study to Evaluate the Efficacy and Safety of SG001 in Combination With Nab-Paclitaxel in Patients With Advanced Triple-Negative Breast Cancer (TNBC) | ||
| NCT04859426 | A Study to Evaluate the Pharmacokinetics and Safety of DBPR108 in Subjects With Hepatic Impairment | ||
| NCT04859452 | A Study to Evaluate the DDI of DBPR108 With Metformin,Glibenclamide,Valsartan, or Simvastatin in Healthy Subjects |
